mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
-0.048 |
0.4 |
mRNA |
SB-431542 |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.4 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
RO-3306 |
GDSC1000 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
TG-101348 |
GDSC1000 |
pan-cancer |
AAC |
-0.023 |
0.4 |
mRNA |
JW-480 |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
Nilotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.03 |
0.4 |